Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001384280 | SCV001583721 | pathogenic | Alkaptonuria | 2023-06-25 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HGD protein function. ClinVar contains an entry for this variant (Variation ID: 1071746). This missense change has been observed in individuals with alkaptonuria (PMID: 9529363, 25681086). This variant is present in population databases (rs373921680, gnomAD 0.009%). This sequence change replaces glutamic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 42 of the HGD protein (p.Glu42Ala). |
Fulgent Genetics, |
RCV001384280 | SCV002792806 | likely pathogenic | Alkaptonuria | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Department Of Human Genetics, |
RCV001384280 | SCV004098948 | pathogenic | Alkaptonuria | no assertion criteria provided | research | The variant was originally described in AKU patient in PMID:9529363. It has been submitted to the HGD gene mutation database (http://hgddatabase.cvtisr.sk/, DB-ID: AKU_00008). |